You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology (Divestiture, in 2017)

Transaction #105360
Investor
1
Sign up to view
Target Company
Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology
Life Science · United States
Seller
1
Sign up to view
30 May 2017
Announced
Target Company
Company Sector Entity Type Status State Country
Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology Life Science Private Active California (CA) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology acquisition deal?
This transaction is an acquisition of Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology (Divestiture) in 2017. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology acquisition happen?
This transaction was announced on 30 May 2017.
What is the deal value of the Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology acquisition?
Deal value information for this transaction is available on AcquityData.
Who are the investors in the Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Sea Lane Biotechnologies LLC - Antibody and Protein Engineering Technology deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial